PANDA Therapeutics
PANDA Therapeutics develops an antibody-based platform targeting protein aggregates involved in Alzheimer’s disease.
CHF 100KVenture Kick Stage III
ParticipantVK
Venture Kick
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
Venture Kick is the Swiss support program whose own news identifies Foldcast and RheoCarti as recipients.
Recorded funding activity
Foldcast designs concrete elements using recyclable molds. RheoCarti develops orthopedic implants, while Stellar Alpina develops propulsion. Each event retains its award or financing instrument rather than being assumed to be private equity.
Sources
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $308.8K 2 disclosed · full round size, not this investor’s share